MCK - McKesson Corp Stock Price, Fair Value and News

$507.40-0.92 (-0.18%)

Delayed as of 22 Oct 2024, 09:59 am ET

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

MCK Price Action

Last 7 days

-0.2%

Last 30 days

0.1%

Last 90 days

-13.2%

Trailing 12 Months

12.3%

MCK RSI Chart

MCK Valuation

Market Cap

66.0B

Price/Earnings (Trailing)

22.3

Price/Sales (Trailing)

0.21

EV/EBITDA

16.06

Price/Free Cashflow

18.71

MCK Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

MCK Fundamentals

MCK Revenue

Revenue (TTM)

313.8B

Rev. Growth (Yr)

6.44%

Rev. Growth (Qtr)

3.83%

MCK Earnings

Earnings (TTM)

3.0B

Earnings Growth (Yr)

-4.49%

Earnings Growth (Qtr)

15.68%

MCK Profitability

Operating Margin

35.44%

EBT Margin

1.21%

Return on Equity

-214.27%

Return on Assets

4.13%

Free Cashflow Yield

5.34%

MCK Investor Care

Dividend Yield

0.47%

Dividend/Share (TTM)

2.4

Buy Backs (1Y)

4.21%

Diluted EPS (TTM)

22.36

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	309.0B	313.8B	0	0
2023	276.7B	284.0B	291.1B	301.5B
2022	264.0B	268.4B	272.0B	273.9B
2021	238.2B	245.2B	251.0B	257.0B
2020	231.1B	231.0B	234.2B	237.6B
2019	214.3B	217.4B	222.0B	224.9B
2018	208.4B	209.9B	210.9B	213.5B
2017	198.5B	199.9B	202.0B	205.4B
2016	190.9B	193.1B	194.3B	196.5B
2015	179.0B	183.1B	187.7B	189.1B
2014	137.4B	148.6B	159.8B	172.0B
2013	122.1B	123.6B	126.8B	130.1B
2012	122.7B	123.5B	123.0B	123.3B
2011	112.1B	114.6B	117.3B	119.9B
2010	108.7B	109.5B	109.9B	109.9B
2009	0	0	107.1B	108.3B

Get all data in R, Python etc through our Historical Stock Data APIs

About McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

CEO	Mr. Brian S. Tyler Ph.D.
WEBSITE	mckesson.com
SECTOR	Healthcare
INDUSTRY	Medical Distribution
EMPLOYEES	45000

McKesson Corp Frequently Asked Questions

What is the ticker symbol for McKesson Corp? What does MCK stand for in stocks?

MCK is the stock ticker symbol of McKesson Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of McKesson Corp (MCK)?

As of Mon Oct 21 2024, market cap of McKesson Corp is 65.99 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MCK stock?

You can check MCK's fair value in chart for subscribers.

Is McKesson Corp a good stock to buy?

The fair value guage provides a quick view whether MCK is over valued or under valued. Whether McKesson Corp is cheap or expensive depends on the assumptions which impact McKesson Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MCK.

What is McKesson Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Oct 21 2024, MCK's PE ratio (Price to Earnings) is 22.3 and Price to Sales (PS) ratio is 0.21. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MCK PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on McKesson Corp's stock?

In the past 10 years, McKesson Corp has provided 0.097 (multiply by 100 for percentage) rate of return.